QHR Technologies Inc. Market Share Analysis

Publisher Name :
Date: 12-Dec-2012
No. of pages: 65

QHR Technologies Inc. Market Share Analysis

Summary

GlobalData’s new report, “QHR Technologies Inc. Market Share Analysis” provides in-depth information on QHR Technologies Inc..’s market position in the clinical IT systems market. The report also provides data and information on the overall competitive landscape within the clinical IT systems market. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Global company shares (in Revenues) information for the clinical IT systems market.
- QHR Technologies Inc..’s company shares (in Revenues) information for all the key countries the company has presence in -Canada.
- QHR Technologies Inc..’s company shares (in Revenues) information for the clinical IT systems market.
- All the key data-points are for 2011 and cover all the key region – North America.
- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company’s value proposition and the business climate it operates in.
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.

Reasons to buy

- Develop sales and marketing strategies by identifying who-stands-where in the markets, QHR Technologies Inc..’s operates in.
- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to QHR Technologies Inc..’s market positions.

QHR Technologies Inc. Market Share Analysis

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 6
2 Introduction 7
2.1 What Is This Report About? 7
3 Definitions of Markets/Categories Covered 8
3.1 Healthcare IT 8
3.1.1 Clinical IT Systems 8
4 Company Snapshot 9
4.1 Key Facts 9
4.2 Company Overview 9
4.3 Financial Performance 9
4.4 SWOT Snapshot 9
4.5 Business Overview 10
4.6 Major Products and Services 10
4.6.1 Overview 10
5 History 11
6 SWOT Analysis 14
6.1 Overview 14
6.2 QHR Technologies Inc. Strengths 14
6.2.1 Niche Market Offerings 14
6.2.2 Management Team 14
6.2.3 Expanding Operating Margin 15
6.3 QHR Technologies Inc. Weaknesses 15
6.3.1 Limited Liquidity Position 15
6.3.2 Geographical Concentration 15
6.4 QHR Technologies Inc. Opportunities 15
6.4.1 Strategic Acquisitions 15
6.4.2 Growing Cloud Computing Markets 15
6.4.3 Growing Global Healthcare-IT Market 16
6.5 QHR Technologies Inc. Threats 16
6.5.1 Global Economic Scenario 16
6.5.2 Rapid Technological Change 16
6.5.3 Government Laws and Regulations 16
7 Competitors 17
8 Competitive Landscape 19
8.1 Healthcare IT (Clinical IT Systems), Global, Market Share (%), 2011 19
8.2 QHR Technologies Inc., Healthcare IT(Clinical IT Systems), by Region, Market Share (2011) 21
8.3 QHR Technologies Inc., Healthcare IT(Clinical IT Systems), by Country, Market Share (2011) 21
9 Key Employees 22
10 Key Employee Biographies 23
11 Company Statement 24
12 Locations And Subsidiaries 26
12.1 Head Office 26
12.2 Other Locations & Subsidiaries 26
13 Financial Deals Landscape 27
13.1 QHR Technologies Inc., Deals Volume Summary, 2006 to YTD 2012 27
14 QHR Technologies Inc. Detailed Deal Summary 29
14.1 Asset Purchase 29
14.1.1 Optimed Software Corporation Of QHR Technologies Acquires MediCentre Assets From iQmedX Software 29
14.2 Equity Offering 30
14.2.1 QHR Technologies Completes Private Placement Of Units For $1 Million 30
14.2.2 QHR Technologies Completes Private Placement Of $1.06 Million 32
14.2.3 CLINICARE Completes Private Placement Of $3 Million 33
14.3 Acquisition 34
14.3.1 QHR Technologies Completes Acquisition Of Open EC Technologies 34
14.3.2 QHR Technologies Completes Acquisition Of EMIS 36
14.3.3 QHR Technologies Completes Acquisition Of CLINICARE 37
14.3.4 QHR Technologies Acquires National Medical Solutions 38
15 Recent Developments 39
15.1 Financial Announcements 39
15.1.1 Nov 09, 2012: QHR Reports Revenue Of CAD7m In Q3 2012 39
15.1.2 Aug 23, 2012: QHR Reports Revenue Of CAD6.9m In Q2 2012 39
15.1.3 May 10, 2012: QHR Reports Revenue Of CAD7.4m In Q1 2012 40
15.1.4 Apr 17, 2012: QHR Reports Revenue Of CAD23.9m In 2011 40
15.1.5 Nov 17, 2011: QHR Reports Revenue Of CAD5.5m In Q3 2011 41
15.1.6 Aug 22, 2011: QHR Reports Revenue Of CAD5.2m In Q2 2011 41
15.1.7 Jun 20, 2011: QHR Reports Total Revenue Of $6.5m In Q1 2011 42
15.1.8 Apr 29, 2011: QHR Reports Revenue Of $19.1m In 2010 43
15.1.9 Nov 25, 2010: QHR Reports Revenue Of $4.6m In Q3 2010 44
15.1.10 Aug 16, 2010: QHR Reports Revenue Of $5.1m In Q2 2010 45
15.1.11 May 27, 2010: QHR Reports Revenue Of $4.7m In Q1 2010 46
15.1.12 May 13, 2009: QHR Posts Total Revenues Of $3.4 million In Q1 2009 46
15.1.13 Apr 20, 2009: QHR Posts Total Revenues Of CAD6.52 Million For 2008 47
15.1.14 Nov 28, 2008: QHR Reports Q3 2008 Results 48
15.1.15 Aug 06, 2008: QHR Reports 2Q 2008 Results 49
15.1.16 Apr 21, 2008: QHR Declares Q1 2008 Results 50
15.1.17 Mar 25, 2008: QHR Declares 2007 Results 50
15.1.18 Nov 27, 2007: QHR Declares Nine Months Ended 2007 Results 52
15.1.19 Aug 17, 2007: QHR Declares First Six Months Ended 2007 Results 52
15.1.20 May 28, 2007: QHR Declares Q1 2007 Results 54
15.2 Corporate Communications 55
15.2.1 Sep 24, 2012: QHR Appoints Gordon Glenn As Chairman 55
15.2.2 Jun 05, 2012: QHR Appoints Jerry Diener As CFO 56
15.2.3 May 19, 2011: QHR Names John Gillberry As Executive Vice President, CFO 56
15.2.4 Oct 15, 2009: QHR Appoints Victoria Withers To Board 57
15.2.5 Sep 30, 2008: QHR Appoints New Board Member 57
15.2.6 Jul 16, 2007: QHR Appoints Board Member 58
15.2.7 Jun 11, 2007: QHR Appoints CFO 58
15.3 Legal and Regulatory 59
15.3.1 Aug 24, 2011: QHR's EMR Division Achieves ISO 13485:2003 Certification 59
15.4 Other Significant Developments 59
15.4.1 Nov 07, 2007: QHR Subsidiary Wins New Contract 59
16 Appendix 60
16.1 Research Methodology 61
16.2 Secondary Research 61
16.3 Primary Research 62
16.4 Models 62
16.5 Forecasts 62
16.6 Expert Panels 63
16.7 GlobalData Consulting 63
16.8 Currency Conversion 64
16.9 Contact Us 65
16.10 Disclaimer 65

1.1 List of Tables
Table 1: QHR Technologies Inc., Key Facts, 2011 9
Table 2: QHR Technologies Inc., SWOT Analysis, 2011 14
Table 3: Healthcare IT (Clinical IT Systems), Global, Company Share by Revenue ($m), 2011 20
Table 4: QHR Technologies Inc., Healthcare IT (Clinical IT Systems), by Region, Revenue ($m) and Market Share (%), 2011 21
Table 5: QHR Technologies Inc., Healthcare IT (Clinical IT Systems), by Country, Revenue ($m) and Market Share (%), 2011 21
Table 6: QHR Technologies Inc., Key Employees 22
Table 7: QHR Technologies Inc., Subsidiaries 26
Table 8: QHR Technologies Inc., Deals Volume Summary, 2006 to YTD 2012 27
Table 9: QHR Technologies Inc., Deals Summary, 2006 to YTD 2012 28
Table 10: Optimed Software Corporation Of QHR Technologies Acquires MediCentre Assets From iQmedX Software 29
Table 11: QHR Technologies Completes Private Placement Of Units For $1 Million 30
Table 12: QHR Technologies Completes Private Placement Of $1.06 Million 32
Table 13: CLINICARE Completes Private Placement Of $3 Million 33
Table 14: QHR Technologies Completes Acquisition Of Open EC Technologies 34
Table 15: QHR Technologies Completes Acquisition Of EMIS 36
Table 16: QHR Technologies Completes Acquisition Of CLINICARE 37
Table 17: QHR Technologies Acquires National Medical Solutions 38
Table 18: USD to Local Currency, Average Exchange Rate, 2011 64

1.2 List of Figures
Figure 1: Healthcare IT (Clinical IT Systems), Global, Market Share (%), 2011 19
Figure 2: QHR Technologies Inc., Deals Volume Summary, 2006 to YTD 2012 27
  • Global Stem Cell Therapy Industry Witnesses Steady Growth
    Stem cell research which is one of the most contemporary areas of biology has developed rapidly in the last couple of years. Increased funding in stem cell research by both government and private organizations is one of the main drivers in the stem cell therapy industry. Stem cells are used in various medical therapies such [...]
  • Global Lubricant Market Driven by Increased Demand in Automotive Industry
    With growth in the automobile industry, the demand for lubricants has also increased. The robust growth in manufacturing with increase in industrial production, particularly in countries such as China and India are also fueling the demand for lubricants. In 2013, the global market for lubricants had reached a value of 123.64 billion USD. By 2020, [...]
  • Global Cybersecurity Market Driven by Increase in Cyber Attacks
    In recent years, the global market for cybersecurity has grown steadily, with the rapid adoption of cloud-based services. As more and more corporate and government organizations are realizing the importance of protecting data and intellectual property, the market for cybersecurity is going to expand. In 2014, the global market for cybersecurity was valued at 95.60 [...]
  • Global Epilepsy Drug Market Continues to Grow Steadily
    The global epilepsy drug market has grown steadily in recent years with increased sales of anti-epileptic drugs which are targeted at reducing seizures. Epilepsy is a condition which affects the brain and is characterized with repeated seizures in the patient. Treatment for epilepsy usually involves the use of medicines known as anti-epileptic drugs which prevents [...]
  • Global Meat and Poultry Product Market to Witness Steady Growth
    As global demand for meat and poultry products continues to rise, the market for meat and poultry is also expected to grow steadily. The market for meat and poultry products is driven by rise in disposable income, growing awareness among consumers about the importance of adding protein to their diet, and change in eating habits. [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Bacterial Pneumonia Global Clinical Trials Review, H2, 2014
    Published: 21-Nov-2014        Price: US $2500 Onwards        Pages: 146
    GlobalData's clinical trial report, "Bacterial Pneumonia Global Clinical Trials Review, H2, 2014" provides data on the Bacterial Pneumonia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bacterial Pneumonia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, ......
  • Aspergillosis Global Clinical Trials Review, H2, 2014
    Published: 21-Nov-2014        Price: US $2500 Onwards        Pages: 125
    GlobalData's clinical trial report, "Aspergillosis Global Clinical Trials Review, H2, 2014" provides data on the Aspergillosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Aspergillosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the ......
  • Cryptococcal Meningitis Global Clinical Trials Review, H2, 2014
    Published: 21-Nov-2014        Price: US $2500 Onwards        Pages: 79
    GlobalData's clinical trial report, "Cryptococcal Meningitis Global Clinical Trials Review, H2, 2014" provides data on the Cryptococcal Meningitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cryptococcal Meningitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, tr......
  • Cerebral (Fatal) Malaria Global Clinical Trials Review, H2, 2014
    Published: 21-Nov-2014        Price: US $2500 Onwards        Pages: 64
    GlobalData's clinical trial report, "Cerebral (Fatal) Malaria Global Clinical Trials Review, H2, 2014" provides data on the Cerebral (Fatal) Malaria clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cerebral (Fatal) Malaria. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase,......
  • African Trypanosomiasis Global Clinical Trials Review, H2, 2014
    Published: 21-Nov-2014        Price: US $2500 Onwards        Pages: 48
    GlobalData's clinical trial report, "African Trypanosomiasis Global Clinical Trials Review, H2, 2014" provides data on the African Trypanosomiasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on African Trypanosomiasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, tr......
  • Cryptosporidiosis Global Clinical Trials Review, H2, 2014
    Published: 21-Nov-2014        Price: US $2500 Onwards        Pages: 58
    GlobalData's clinical trial report, "Cryptosporidiosis Global Clinical Trials Review, H2, 2014" provides data on the Cryptosporidiosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cryptosporidiosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, promin......
  • Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, H2, 2014
    Published: 21-Nov-2014        Price: US $2500 Onwards        Pages: 70
    GlobalData's clinical trial report, "Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, H2, 2014" provides data on the Cytomegalovirus (CMV) Retinitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cytomegalovirus (CMV) Retinitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical t......
  • Dermatophytosis Global Clinical Trials Review, H2, 2014
    Published: 21-Nov-2014        Price: US $2500 Onwards        Pages: 86
    GlobalData's clinical trial report, "Dermatophytosis Global Clinical Trials Review, H2, 2014" provides data on the Dermatophytosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dermatophytosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence o......
  • Bacterial Sepsis Global Clinical Trials Review, H2, 2014
    Published: 21-Nov-2014        Price: US $2500 Onwards        Pages: 65
    GlobalData's clinical trial report, "Bacterial Sepsis Global Clinical Trials Review, H2, 2014" provides data on the Bacterial Sepsis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bacterial Sepsis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominenc......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs